{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:17:16Z","timestamp":1788351436671,"version":"build-2803163510"},"reference-count":41,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The tumor microenvironment, particularly the tumor stroma, plays a critical role in tumor progression, immune evasion, and therapeutic resistance. However, its interaction with the immune landscape in rectal cancer (RC) remains incompletely understood. This study aimed to comprehensively characterize the stromal-immune ecosystem associated with the tumor stroma ratio (TSR) in RC and to evaluate its clinical and therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed a multicenter cohort of 498 patients with treatment-na\u00efve RC in whom TSR was assessed on H&amp;E-stained sections. Integrative multi-omics analyses were performed, including bulk RNA sequencing (n=118) and single-cell RNA\/T-cell receptor (TCR) sequencing (n=10). Key findings were validated by immunohistochemistry (n=114) and multiplex immunofluorescence (n=20). Survival analyses and statistical comparisons were conducted to evaluate clinical associations and treatment responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High TSR was an independent predictor of unfavorable disease-free survival and cancer-specific survival and was associated with aggressive clinicopathological features. Single-cell analyses revealed that TSR-high tumors exhibited a profoundly immunosuppressive microenvironment, characterized by clonally expanded terminally exhausted CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells (CD8\n                      <jats:sup>+<\/jats:sup>\n                      Tex-CXCL13) and activated CD4\n                      <jats:sup>+<\/jats:sup>\n                      regulatory T cells (CD4\n                      <jats:sup>+<\/jats:sup>\n                      Treg-TNFRSF4). Two LRRC15\n                      <jats:sup>+<\/jats:sup>\n                      cancer-associated fibroblast (CAF) subsets (mCAF-CTHRC1 and mCAF-FAP) were enriched in TSR-high tumors. Among them, mCAF-CTHRC1 was associated with increased Treg abundance and activation features, with predicted interactions with CD4\n                      <jats:sup>+<\/jats:sup>\n                      Treg-TNFRSF4 cells through the LGALS9\u2013CD44 signaling axis. In addition, SPP1-expressing monocytes (Mon-SPP1) and malignant epithelial cells were prominent in TSR-high tumors and showed a predicted SPP1\u2013CD44 interaction with T-cell subsets, suggesting potential involvement in immunosuppressive stromal-immune interactions. In patients receiving neoadjuvant therapy, pretreatment TSR-low tumors showed improved pathological response and survival outcomes compared with TSR-high tumors. In the neoadjuvant chemoradiotherapy plus immunotherapy cohort, TSR-low tumors were associated with a significantly higher major pathological response rate, whereas pathological complete response showed a non-significant trend in the same direction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>High TSR identifies a clinically aggressive subtype of RC characterized by a profoundly immunosuppressive stromal-immune ecosystem enriched for exhausted T cells, immunosuppressive CAF programs, and SPP1-associated stromal-myeloid interactions. These findings highlight LGALS9\u2212, LRRC15\u2212, and SPP1-related stromal-immune pathways as candidate stromal-immune therapeutic vulnerabilities that warrant further mechanistic and preclinical validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015376","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:20:13Z","timestamp":1785759613000},"page":"e015376","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor stroma-immune interactions shape the immunosuppressive microenvironment and predict response to neoadjuvant chemoradiotherapy plus immunotherapy in rectal cancer"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-8847","authenticated-orcid":false,"given":"Qianyu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[{"name":"The Seventh Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guole","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"The Seventh Medical Center, Chinese PLA General Hospital, Beijing, China"},{"name":"Senior Department of General Surgery, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyun","family":"Cai","sequence":"additional","affiliation":[{"name":"The Seventh Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Du","sequence":"additional","affiliation":[{"name":"Senior Department of General Surgery, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-4271","authenticated-orcid":false,"given":"Junfeng","family":"Du","sequence":"additional","affiliation":[{"name":"The Seventh Medical Center, Chinese PLA General Hospital, Beijing, China"},{"name":"Senior Department of General Surgery, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5388-2874","authenticated-orcid":false,"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026090204350540000_14.8.e015376.1","doi-asserted-by":"publisher","DOI":"10.3322\/CAAC.21834"},{"key":"2026090204350540000_14.8.e015376.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"2026090204350540000_14.8.e015376.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01670-1","article-title":"Targeting the tumor stroma for cancer therapy","volume":"21","author":"Xu","year":"2022","journal-title":"Mol Cancer"},{"key":"2026090204350540000_14.8.e015376.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0007-1"},{"key":"2026090204350540000_14.8.e015376.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105152","article-title":"Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer","volume":"104","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"key":"2026090204350540000_14.8.e015376.6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt593"},{"key":"2026090204350540000_14.8.e015376.7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318260dfe8"},{"key":"2026090204350540000_14.8.e015376.8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41416-020-0847-1","article-title":"Tumour budding and tumour-stroma ratio in hepatocellular carcinoma","volume":"123","author":"Kairaluoma","year":"2020","journal-title":"Br J Cancer"},{"key":"2026090204350540000_14.8.e015376.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103054","article-title":"Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer","volume":"61","author":"Zhao","year":"2020","journal-title":"EBioMedicine"},{"key":"2026090204350540000_14.8.e015376.10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41416-022-02049-1","article-title":"The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)","volume":"128","author":"Xu","year":"2023","journal-title":"Br J Cancer"},{"key":"2026090204350540000_14.8.e015376.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.015"},{"key":"2026090204350540000_14.8.e015376.12","doi-asserted-by":"crossref","first-page":"E1095","DOI":"10.1093\/neuros\/nyz333","article-title":"The Relationship Between Tumor-Stroma Ratio, the Immune Microenvironment, and Survival in Patients With Spinal Chordoma","volume":"85","author":"Zou","year":"2019","journal-title":"Neurosurgery"},{"key":"2026090204350540000_14.8.e015376.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"2026090204350540000_14.8.e015376.14","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060901","article-title":"Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer","volume":"11","author":"Ahmad","year":"2021","journal-title":"Biomolecules"},{"key":"2026090204350540000_14.8.e015376.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-2058-1","article-title":"The role of collagen in cancer: from bench to bedside","volume":"17","author":"Xu","year":"2019","journal-title":"J Transl Med"},{"key":"2026090204350540000_14.8.e015376.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.021"},{"key":"2026090204350540000_14.8.e015376.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6"},{"key":"2026090204350540000_14.8.e015376.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat Commun"},{"key":"2026090204350540000_14.8.e015376.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.011"},{"key":"2026090204350540000_14.8.e015376.20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"2026090204350540000_14.8.e015376.21","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/neuonc\/noaf157","article-title":"CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma","volume":"27","author":"Luo","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026090204350540000_14.8.e015376.22","doi-asserted-by":"crossref","unstructured":"Liu S , Zhang Z , Wang Z , et al . SPP1 drives colorectal cancer liver metastasis and immunotherapy resistance by stimulating CXCL12 production in cancer-associated fibroblasts. Cancer Res 2025. doi:10.1158\/0008-5472.c.8227052","DOI":"10.1158\/0008-5472.c.8227052"},{"key":"2026090204350540000_14.8.e015376.23","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400622RR","article-title":"SPP1 could be an immunological and prognostic biomarker: From pan-cancer comprehensive analysis to osteosarcoma validation","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J"},{"key":"2026090204350540000_14.8.e015376.24","doi-asserted-by":"crossref","unstructured":"Dang H , van Pelt GW , Haasnoot KJC , et al . Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study. United European Gastroenterol J 2021. doi:10.1177\/2050640620975324","DOI":"10.1177\/2050640620975324"},{"key":"2026090204350540000_14.8.e015376.25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cac2.12613","article-title":"Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms","volume":"45","author":"Yao","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"2026090204350540000_14.8.e015376.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0281-y"},{"key":"2026090204350540000_14.8.e015376.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022"},{"key":"2026090204350540000_14.8.e015376.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30789-X"},{"key":"2026090204350540000_14.8.e015376.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101091","article-title":"Tumor-Infiltrating Immune Cells in Colorectal Cancer","volume":"59","author":"Ferkel","year":"2025","journal-title":"Neoplasia"},{"key":"2026090204350540000_14.8.e015376.30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1149622","article-title":"Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer","volume":"14","author":"Ding","year":"2023","journal-title":"Front Immunol"},{"key":"2026090204350540000_14.8.e015376.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.022"},{"key":"2026090204350540000_14.8.e015376.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104971","article-title":"Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma","volume":"100","author":"Zhang","year":"2024","journal-title":"EBioMedicine"},{"key":"2026090204350540000_14.8.e015376.33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/1751-2980.70001","article-title":"CXCL13 as a Prognostic Biomarker and Modulator of the Tumor Microenvironment in Colorectal Cancer","volume":"26","author":"Guo","year":"2025","journal-title":"J Dig Dis"},{"key":"2026090204350540000_14.8.e015376.34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1476904","article-title":"CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"2026090204350540000_14.8.e015376.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01204-2","article-title":"Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies","volume":"21","author":"Xu","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2026090204350540000_14.8.e015376.36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1113378","article-title":"CAFs orchestrates tumor immune microenvironment-A new target in cancer therapy?","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026090204350540000_14.8.e015376.37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat Commun"},{"key":"2026090204350540000_14.8.e015376.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05272-1"},{"key":"2026090204350540000_14.8.e015376.39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat Commun"},{"key":"2026090204350540000_14.8.e015376.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02683-x"},{"key":"2026090204350540000_14.8.e015376.41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","article-title":"The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells","volume":"4","author":"Brina","year":"2023","journal-title":"Nat Cancer"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:35:17Z","timestamp":1788348917000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jitc-2026-015376"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015376","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}